查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654214

細胞治療成分市場規模、佔有率、趨勢分析報告：按產品、最終用途、地區、細分市場預測，2025 年至 2030 年

Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report By Product (Media, Sera, Antibodies, Reagents & Buffers, Cell Culture Supplements), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

細胞治療材料市場的成長和趨勢

根據Grand View Research, Inc.的一份新報告，到2030年全球細胞治療材料市場規模預計將達到125.9億美元。

預計 2025 年至 2030 年間，市場複合年成長率將達到 18.16%。預計對各種細胞藥物研發的投資增加以及許多國家政府對各種臨床研究的投資增加將有助於市場的成長。此外，新興國家生物製藥和生物技術產業的不斷發展將進一步推動預測期內的市場成長。

COVID-19疫情對細胞治療材料產業產生了重大影響。隨著病毒在全球蔓延，供應鏈中斷、勞動力短缺和運輸限制對製造細胞療法所需的關鍵原料的生產和分配構成了重大挑戰。許多供應商在採購和交付生長因子、培養基和生物反應器等基本成分時面臨延誤。結果，細胞治療公司經歷了生產放緩和成本增加。此外，疫情期間對醫療用品的需求增加，導致資源緊張並導致價格波動。儘管面臨這些挑戰，細胞治療產業仍透過適應新的籌資策略和監管變化表現出了韌性，凸顯了供應鏈多樣化和為不可預見的全球危機做好準備的重要性。

此外，預計細胞治療產業將見證生物製藥公司的進步和創新的大幅成長。對於治療各種疾病和病症的有效細胞療法的需求日益成長，將進一步推動這些進步。此外，預計預測期內各種生物技術和製藥公司的擴張將進一步推動市場成長。

細胞療法製造的不斷擴張以及 FDA核准的增加為原料市場帶來了許多機會。一些製造商正在開設此類設施，以擴大其在細胞治療領域的影響力。例如，2023年6月，百時美施貴寶獲得美國FDA核准，在其位於麻薩諸塞州德文斯的新細胞療法製造工廠開始商業化生產。為了確保公司治療產品組合的長期供應，Devens 工廠是 BMS 全球細胞治療製造基礎設施的重要組成部分。

然而，成本和定價正在限制市場的成長。這些對於細胞療法生產至關重要的材料的取得和製造成本很高。這種成本負擔增加了開發和提供細胞治療方法的費用，並且可能由於財務限制而限制更多人群獲得治療。平衡品質和價格是推動細胞療法和確保其在醫療行業更廣泛可用和接受的關鍵挑戰。

細胞治療材料市場報告重點

  • 市場按產品細分為培養基、血清、細胞培養補充劑、抗體、試劑和緩衝液等。 2024 年，細胞培養補充劑部分佔據最大的市場佔有率，為 25.27%。
  • 根據最終用途，市場細分為生物製藥和製藥公司、CMO 和 CRO 以及其他。 2024年，生物製藥和製藥公司板塊佔據最大的市場佔有率，為53.54%。
  • 2024 年北美佔據細胞治療原料產業的主導地位，佔有率為 47.30%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第4章 產品業務分析

  • 產品細分儀表板
  • 細胞治療材料市場：產品變化分析
  • 2018 年至 2030 年細胞治療原料市場規模及趨勢分析（依產品分類）
  • 培養基
    • 文化媒體市場，2018-2030
  • 血清
    • 血清市場，2018-2030
  • 細胞培養補充劑
    • 細胞培養補充品市場，2018-2030 年
  • 抗體
    • 抗體市場，2018 - 2030
  • 試劑和緩衝溶液
    • 2018 至 2030 年試劑與緩衝液市場
  • 其他
    • 其他市場，2018-2030

第5章 最終用途業務分析

  • 細胞治療材料市場：最終用途趨勢分析
  • 生物製藥和製藥公司
    • 2018-2030 年生物製藥和醫藥市場
  • 合約研究公司,合約行銷公司
    • CRO/CMO 市場，2018 年至 2030 年
  • 其他
    • 其他市場，2018-2030

第6章 區域經營分析

  • 細胞治療材料市場佔有率（按地區分類） (2024 年和 2030 年)
  • 北美洲
    • 2018 至 2030 年北美細胞治療材料市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018 至 2030 年歐洲細胞治療材料市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太細胞治療材料市場
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2018 年至 2030 年拉丁美洲細胞治療材料市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018 年至 2030 年中東和非洲細胞治療材料市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 公司分類
  • 戰略地圖
  • Company Position Analysis, 2024
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Actylis.
    • ACROBiosystems
    • STEMCELL Technologies
    • Grifols, SA
    • Charles River Laboratories
    • RoosterBio, Inc.
    • PromoCell GmbH
    • Danaher
    • Sartorius Stedim BIoTech
Product Code: GVR-4-68040-137-9

Cell Therapy Raw Materials Market Growth & Trends:

The global cell therapy raw materials market size is anticipated to reach USD 12.59 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 18.16% from 2025 to 2030. The rising investments in the research and development of various cell-based drugs and the increasing number of government investments in numerous countries for various clinical studies are anticipated to contribute to the growth of the market. Moreover, the growing developments in the biopharmaceutical & biotechnology industry in developing countries are further fueling the growth of the market over the forecast period.

The COVID-19 pandemic had a significant impact on the cell therapy raw materials industry. As the virus spread globally, disruptions in supply chains, workforce shortages, and transportation restrictions posed significant challenges to the production and distribution of critical raw materials required for cell therapy manufacturing. Many suppliers faced delays in the sourcing and delivery of essential components, such as growth factors, culture media, and bioreactors. This resulted in production slowdowns and increased costs for cell therapy companies. In addition, the heightened demand for medical supplies during the pandemic strained resources and led to price fluctuations. Despite these challenges, the cellular therapy industry demonstrated resilience by adapting to new sourcing strategies and regulatory changes, emphasizing the importance of supply chain diversification and preparedness in the face of unforeseen global crises.

Moreover, the cell therapy industry is anticipated to witness a significant surge in advancements and innovations by biopharma companies. These advances would be further propelled by the growing demand for effective cell-based therapies to treat a range of diseases and medical conditions. Furthermore, the growing expansion of various biotechnology and pharmaceutical companies is further expected to propel the growth of the market over the forecast period.

The increasing expansion of cellular therapy manufacturing along with rising FDA approvals are opening numerous opportunities for the raw materials market. Several manufacturers are opening such facilities to increase their footprint in the cellular therapy field. For instance, in June 2023, Bristol Myers Squibb received approval from the U.S. FDA to start its commercial production at its new cell therapy production facility in Devens, Massachusetts. For the long-term supply of the company's therapy portfolio, the Devens site is a crucial part of BMS' growing worldwide cell therapy production infrastructure.

However, the cost and affordability restrain the growth of the market. These materials, vital for cell therapy production, are costly to obtain and manufacture. This cost burden increases the expenses in the development and provision of cell-based therapies, potentially limiting their accessibility to a broader population due to financial constraints. Balancing quality and affordability is an acute concern in advancing cell therapies and ensuring their broader availability and acceptance within the healthcare industry.

Cell Therapy Raw Materials Market Report Highlights:

  • Based on product, the market is segmented into media, sera, cell culture supplements, antibodies, reagents & buffers, and others. The cell culture supplements segment held the largest market share of 25.27% in 2024.
  • Based on the end use, the market is segmented into biopharmaceutical & pharmaceutical companies, CMOs & CROs, and others. The biopharmaceutical & pharmaceutical companies segment held the largest market share of 53.54% in 2024.
  • North America dominated the cell therapy raw materials industry with a share of 47.30% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations
  • 1.12. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising demand for cell therapies
      • 3.2.1.2. Advancements in research and development for cell-based therapies
      • 3.2.1.3. Technological Innovation
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with the production and procurement of raw materials
      • 3.2.2.2. Stringent regulations associated with cell therapies
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Cell Therapy Raw Materials Market: Product Movement Analysis
  • 4.3. Cell Therapy Raw Materials Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
  • 4.4. Media
    • 4.4.1. Media Market, 2018 - 2030 (USD Million)
  • 4.5. Sera
    • 4.5.1. Sera Market, 2018 - 2030 (USD Million)
  • 4.6. Cell Culture Supplements
    • 4.6.1. Cell Culture Supplements Market, 2018 - 2030 (USD Million)
  • 4.7. Antibodies
    • 4.7.1. Antibodies Market, 2018 - 2030 (USD Million)
  • 4.8. Reagents & Buffers
    • 4.8.1. Reagents & Buffers Market, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. End Use Business Analysis

  • 5.1. Cell Therapy Raw Materials Market: End Use Movement Analysis
  • 5.2. Biopharmaceutical & Pharmaceutical Companies
    • 5.2.1. Biopharmaceutical & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 5.3. CROs & CMOs
    • 5.3.1. CROs & CMOs Market, 2018 - 2030 (USD Million)
  • 5.4. Others
    • 5.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Cell Therapy Raw Materials Market Share By Region, 2024 & 2030
  • 6.2. North America
    • 6.2.1. North America Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Competitive Scenario
      • 6.2.4.3. Regulatory Framework
      • 6.2.4.4. Mexico Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. UK Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Germany Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. France Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Italy Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Spain Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Denmark Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Sweden Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Norway Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Japan Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. China Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. India Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Australia Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Thailand Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. South Korea Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Brazil Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Argentina Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. South Africa Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Saudi Arabia Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. UAE Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Kuwait Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Position Analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Thermo Fisher Scientific Inc.
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Merck KGaA
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Actylis.
      • 7.4.3.1. Overview
      • 7.4.3.2. Product Benchmarking
      • 7.4.3.3. Strategic Initiatives
    • 7.4.4. ACROBiosystems
      • 7.4.4.1. Overview
      • 7.4.4.2. Product Benchmarking
      • 7.4.4.3. Strategic Initiatives
    • 7.4.5. STEMCELL Technologies
      • 7.4.5.1. Overview
      • 7.4.5.2. Product Benchmarking
      • 7.4.5.3. Strategic Initiatives
    • 7.4.6. Grifols, S.A.
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Charles River Laboratories
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. RoosterBio, Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Product Benchmarking
      • 7.4.8.3. Strategic Initiatives
    • 7.4.9. PromoCell GmbH
      • 7.4.9.1. Overview
      • 7.4.9.2. Product Benchmarking
      • 7.4.9.3. Strategic Initiatives
    • 7.4.10. Danaher
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Sartorius Stedim Biotech
      • 7.4.11.1. Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives

List of Tables

  • Table 1 Global cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 2 Global cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 3 Global cell therapy raw materials market, by region, 2018 - 2030 (USD Million)
  • Table 4 North America cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 5 North America cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 6 North America cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 7 U.S. cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 8 U.S. cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 9 Canada cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 11 Mexico cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 12 Mexico cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 13 Europe cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 15 Europe cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 16 UK cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 17 UK cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 18 Germany cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 19 Germany cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 20 France cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 21 France cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 22 Italy cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 23 Italy cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 24 Spain cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 25 Spain cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 26 Denmark cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 27 Denmark cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 28 Sweden cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 29 Sweden cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 30 Norway cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 31 Norway cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 35 Japan cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 36 Japan cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 37 China cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 38 China cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 39 India cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 40 India cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 41 Australia cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 42 Australia cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 43 South Korea cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 44 South Korea cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 45 Thailand cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 46 Thailand cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 47 Latin America cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 48 Latin America cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 49 Latin America cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 50 Brazil cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 51 Brazil cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 52 Argentina cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 53 Argentina cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 57 South Africa cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 58 South Africa cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 61 UAE cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 62 UAE cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 63 Kuwait cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 64 Kuwait cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 65 Key companies undertaking acquisitions
  • Table 66 Key companies launching new products/services
  • Table 67 Key companies undertaking collaborations and partnerships
  • Table 68 Key companies undertaking other initiatives

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Cell therapy raw materials market segmentation
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Value-chain-based sizing & forecasting
  • Fig. 10 QFD modelling for market share assessment
  • Fig. 11 Market formulation & validation
  • Fig. 12 Commodity flow analysis
  • Fig. 13 Market snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Segment snapshot
  • Fig. 16 Competitive landscape snapshot
  • Fig. 17 Market trends & outlook
  • Fig. 18 Porter's five force analysis
  • Fig. 19 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal)
  • Fig. 20 Cell therapy raw materials market: product outlook key takeaways
  • Fig. 21 Cell therapy raw materials market: product movement analysis
  • Fig. 22 Media market, 2018 - 2030 (USD Million)
  • Fig. 23 Sera market, 2018 - 2030 (USD Million)
  • Fig. 24 Cell culture supplements market, 2018 - 2030 (USD Million)
  • Fig. 25 Antibodies market, 2018 - 2030 (USD Million)
  • Fig. 26 Reagents & buffers market, 2018 - 2030 (USD Million)
  • Fig. 27 Others market, 2018 - 2030 (USD Million)
  • Fig. 28 Cell therapy raw materials market: end Use outlook key takeaways
  • Fig. 29 Cell therapy raw materials market: end Use movement analysis
  • Fig. 30 Biopharmaceutical & pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 31 CROs & CMOs supplements market, 2018 - 2030 (USD Million)
  • Fig. 32 Others supplements market, 2018 - 2030 (USD Million)
  • Fig. 33 Cell therapy raw materials market revenue, by region, 2022 & 2030 (USD Million)
  • Fig. 34 Regional marketplace: key takeaways
  • Fig. 35 North America cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 US cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 US Key country dynamics
  • Fig. 38 Canada cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Canada Key country dynamics
  • Fig. 40 Mexico cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico Key country dynamics
  • Fig. 42 Europe cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 UK cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 UK Key country dynamics
  • Fig. 45 Germany cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Germany Key country dynamics
  • Fig. 47 France cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 France Key country dynamics
  • Fig. 49 Spain cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Spain Key country dynamics
  • Fig. 51 Italy cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Italy Key country dynamics
  • Fig. 53 Denmark cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark Key country dynamics
  • Fig. 55 Sweden cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden Key country dynamics
  • Fig. 57 Norway cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Norway Key country dynamics
  • Fig. 59 Asia Pacific cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Japan cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Japan Key country dynamics
  • Fig. 62 China cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 China Key country dynamics
  • Fig. 64 India cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 India Key country dynamics
  • Fig. 66 Australia cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Australia Key country dynamics
  • Fig. 68 South Korea cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 South Korea Key country dynamics
  • Fig. 70 Thailand cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Thailand Key country dynamics
  • Fig. 72 Latin America cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Brazil cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Brazil Key country dynamics
  • Fig. 75 Argentina cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Argentina Key country dynamics
  • Fig. 77 MEA cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 South Africa Key country dynamics
  • Fig. 80 Saudi Arabia cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Saudi Arabia Key country dynamics
  • Fig. 82 UAE cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 UAE Key country dynamics
  • Fig. 84 Kuwait cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Kuwait Key country dynamics
  • Fig. 86 Market participant categorization
  • Fig. 87 Strategic framework